BioAdaptives, Inc. is launching an enhanced product line for holistic healthcare practitioners. The next generation products are more advanced versions of proven existing nutraceuticals with changes to ingredients, dose and/or composition. These symptoms are challenging for patients and the professionals who want to help manage their clients' health needs.

Increasingly, professionals are finding success in utilizing products because they contain ingredients that are known to have neuro-protective, anti-viral, anti-inflammatory and antioxidant properties. Furthermore, as part of a holistic approach, products are reported to elevate mood and promote a calming effect." About BioAdaptives, Inc.BioAdaptives, Inc. manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, anti-viral activity and immune system defense; resistance to stress; endurance; recovery from injury, illness and exercise; and anti-aging properties. The Company's current dietary supplement formulations are carefully selected from the best worldwide sources and utilize proprietary methods of enhancing the bioavailability of nutrients.

The products for horses and dogs have also demonstrated increased general health, competitive performance enhancement, rejuvenation effects, and pain relief, as well as providing improvements in appearance. Current product line includes PrimiLungs(TM) and PluriPain(R) for humans and Equine All-in-One(TM) for horses. Additional human products, to be introduced soon, are designed to aid memory, cognition and focus; assist in sleep and fatigue reduction; and improve overall emotional and physical wellness.

BioAdaptives' common shares trade in the OTC market under the symbol BDPT. It has over 13,000 current shareholders. None of the statements about the Company's products have been approved by the Food and Drug Administration.